263 related articles for article (PubMed ID: 26575940)
1. C-Terminal Domain of Integrase Binds between the Two Active Sites.
Roberts VA
J Chem Theory Comput; 2015 Sep; 11(9):4500-11. PubMed ID: 26575940
[TBL] [Abstract][Full Text] [Related]
2. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
[TBL] [Abstract][Full Text] [Related]
3. Insight into the binding mode between N-methyl pyrimidones and prototype foamy virus integrase-DNA complex by QM-polarized ligand docking and molecular dynamics simulations.
Reddy KK; Singh SK
Curr Top Med Chem; 2015; 15(1):43-9. PubMed ID: 25579571
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystal structure of the N-terminal region of Moloney murine leukemia virus integrase and its implications for viral DNA recognition.
Guan R; Aiyer S; Cote ML; Xiao R; Jiang M; Acton TB; Roth MJ; Montelione GT
Proteins; 2017 Apr; 85(4):647-656. PubMed ID: 28066922
[TBL] [Abstract][Full Text] [Related]
5. Outer domains of integrase within retroviral intasomes are dispensible for catalysis of DNA integration.
Li M; Lin S; Craigie R
Protein Sci; 2016 Feb; 25(2):472-8. PubMed ID: 26537415
[TBL] [Abstract][Full Text] [Related]
6. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.
Balasubramanian S; Rajagopalan M; Bojja RS; Skalka AM; Andrake MD; Ramaswamy A
J Biomol Struct Dyn; 2017 Dec; 35(16):3469-3485. PubMed ID: 27835934
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the Rous sarcoma virus intasome.
Yin Z; Shi K; Banerjee S; Pandey KK; Bera S; Grandgenett DP; Aihara H
Nature; 2016 Feb; 530(7590):362-6. PubMed ID: 26887497
[TBL] [Abstract][Full Text] [Related]
8. Retroviral prototype foamy virus intasome binding to a nucleosome target does not determine integration efficiency.
Kotlar RM; Jones ND; Senavirathne G; Gardner AM; Messer RK; Tan YY; Rabe AJ; Fishel R; Yoder KE
J Biol Chem; 2021; 296():100550. PubMed ID: 33744295
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the functional domains of human foamy virus integrase using chimeric integrases.
Lee HS; Kang SY; Shin CG
Mol Cells; 2005 Apr; 19(2):246-55. PubMed ID: 15879710
[TBL] [Abstract][Full Text] [Related]
10. An effective HIV-1 integrase inhibitor screening platform: Rationality validation of drug screening, conformational mobility and molecular recognition analysis for PFV integrase complex with viral DNA.
Du W; Zuo K; Sun X; Liu W; Yan X; Liang L; Wan H; Chen F; Hu J
J Mol Graph Model; 2017 Nov; 78():96-109. PubMed ID: 29055187
[TBL] [Abstract][Full Text] [Related]
11. Substrate recognition and motion mode analyses of PFV integrase in complex with viral DNA via coarse-grained models.
Hu J; Liu M; Tang D; Chang S
PLoS One; 2013; 8(1):e54929. PubMed ID: 23365687
[TBL] [Abstract][Full Text] [Related]
12. Prototype foamy virus integrase is promiscuous for target choice.
Mackler RM; Lopez MA; Osterhage MJ; Yoder KE
Biochem Biophys Res Commun; 2018 Sep; 503(3):1241-1246. PubMed ID: 30017200
[TBL] [Abstract][Full Text] [Related]
13. Solution conformations of prototype foamy virus integrase and its stable synaptic complex with U5 viral DNA.
Gupta K; Curtis JE; Krueger S; Hwang Y; Cherepanov P; Bushman FD; Van Duyne GD
Structure; 2012 Nov; 20(11):1918-28. PubMed ID: 23000384
[TBL] [Abstract][Full Text] [Related]
14. Assembly of prototype foamy virus strand transfer complexes on product DNA bypassing catalysis of integration.
Yin Z; Lapkouski M; Yang W; Craigie R
Protein Sci; 2012 Dec; 21(12):1849-57. PubMed ID: 23011895
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional insights into foamy viral integrase.
Hossain MA; Ali MK; Shin CG
Viruses; 2013 Jul; 5(7):1850-66. PubMed ID: 23872492
[TBL] [Abstract][Full Text] [Related]
16. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
Zhu HM; Chen WZ; Wang CX
Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
[TBL] [Abstract][Full Text] [Related]
17. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
[TBL] [Abstract][Full Text] [Related]
18. Integrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding.
Serrao E; Krishnan L; Shun MC; Li X; Cherepanov P; Engelman A; Maertens GN
Nucleic Acids Res; 2014 Apr; 42(8):5164-76. PubMed ID: 24520116
[TBL] [Abstract][Full Text] [Related]
19. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.
Heuer TS; Brown PO
Biochemistry; 1998 May; 37(19):6667-78. PubMed ID: 9578550
[TBL] [Abstract][Full Text] [Related]
20. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
Heuer TS; Brown PO
Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
